DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNAs pattern, and demonstrates unfavorable outcome resembling those with MYD88 L265P mutation. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.